Laredo

Mirena IUD Lawyers Accepting Mirena IUD Lawsuits Nationwide

Free Legal Shield Mirena IUD Lawyers are accepting Mirena IUD cases where the device has migrated from position to the uterus, abdomen or a nearby organ. The device becomes embedded and causes a perforation and usually needs to be surgically removed.

Can you answer yes to any of these questions? If so, we need to hear from you today.

Were there any complications with the original insertion?
Do you have a perforation?
Has the device been surgically removed?

Symptoms to watch out for include:

Lower abdominal pain
Heavy vaginal bleeding
Inability to locate the Mirena IUD string
Bloating,and pain in the abdomen
Nausea, Vomiting, Chills, Fever and Rapid heartbeat

Serious side effects that have been linked to Mirena include:

  • Embedment in the uterus
  • Embedment in the abdomen or a nearby organ
  • Erosion of adjacent areas such as the vagina
  • Intestinal perforations or obstruction
  • Perforation of the uterus

Mirena IUD Lawsuits Alert

Mirena IUD lawyers are filing Mirena lawsuits for a implanted Mirena IUD needing to be surgically removed because it migrated from its original position and perforated the uterine lining, You may have a potential Mirena lawsuit.

Legal Shield has launched an aggressive outreach campaign to locate all women who have had a perforation of the uterus or abdomen or another organ.

Lawyers for Airplane Accidents and Aviation Crash Injuries

Nationwide Airplane Crash Lawyers

Nationwide Lawyers for Airplane Accidents and Aviation Crash Injuries

An airplane disaster with loss of life can be devastating to a family and can cause severe emotional distress. If you or a loved one is a victim of an aircraft accident, control tower misconduct, or pilot negligence, not only do you need an aggressive airplane accident lawyer, but you also need emotional support. An airplane disaster can affect you for months, and live in your memory for years. Our experienced airplane crash lawyers provide effective representation while understanding your emotional needs after such a traumatic experience.

When an airplane crash occurs, people try to make sense of what happened in order to deal with the anxiety and stress of the situation. Emotional and psychological trauma results from the extraordinarily stressful event. This may shatter your sense of security, making you feel helpless and vulnerable in a dangerous world. The emotional damage can linger long after the crisis is over and a permanent mark may be left on your psyche. Further, airplane accident lawsuits do not settle quickly or easily thus, adding to your overall stress. For this reason, your choice of an airplane accident law firm is extremely important. A law firm inexperienced with these disasters may not understand the extent of your emotional trauma. The aircraft disaster team at Injury Lawyers USA has over 15 years of experience, as they have served the needs of airplane crash victims since 1996.

After a disaster of this magnitude, you may begin to have some common psychological reactions such as:

– Disbelief, shock, and post traumatic stress
– Fear and anxiety about the present and the future
– Disorientation; difficulty making decisions or concentrating
– Apathy and emotional numbing
– Nightmares and reoccurring thoughts about the event
– Irritability, anger, and occasional outbursts
– Sadness and depression
– Feeling powerless
– Changes in eating patterns; loss of appetite or overeating
– Crying for “no apparent reason”
– Headaches, back pains, and stomach problems
– Difficulty sleeping or falling asleep; sleep deprivation symptoms
– Increased use of alcohol and drugs

Facts About Airplane Accident Law

Airplanes are considered common carriers. This means that aircraft employees are required to use the highest degree of care in transporting you to your destination. The airplane carrier is also required to inspect and maintain all equipment, and workers are required to have the skill to carry out their duties in order to protect your safety. When the airline fails to uphold these safety standards, accidents can occur. The airplane accident lawyers at Injury Lawyers USA will argue that the airline failed to satisfy its duty of the highest care to you.


If you or a loved one has been injured in an airplane accident, seek out a law office that will aggressively pursue your case while providing you with the care and concern you deserve. As it may be difficult to make decisions during a time of such vulnerability, it is necessary to trust the airplane crash lawyer you retain. Injury Lawyers USA is here for you. Our lawyers are experienced in dealing with such issues are available to guide you and help you during this difficult time.

Airplane crashes and injuries can be caused by:

-Dangerous conditions inside the aircraft
-Careless handling of the aircraft
-Severe turbulence
-Negligent actions by incompetent flight staff
-Faulty maintenance of the aircraft and equipment
-Poor flight and airport traffic control
-Faulty equipment at the airport

Many federal, state, and international laws regulate standards for the maintenance, operation, and safety of airplanes. However, even though these laws help protect passengers of airlines, an accident may still happen. Aviation law covers personal injuries that occur aboard aircraft, including slip and fall accidents and wrongful deaths that may occur in the rare case that an airplane crashes. The laws are highly specialized, and the causes of airplane accidents may be difficult to determine. Our lawyers are skilled litigators assisting crash victims and families nationwide and internationally. If you or a loved one has been injured in an airplane accident, your lawyer can review your case, protect your rights, and help you get the compensation you deserve. Our airplane accident lawyers at Injury Lawyers USA are supportive of your personal and emotional needs and fierce in their legal representation.

Contact us if you or a loved one has been a victim of:

U.S. airline accident l awyer ,
Private aircraft accident lawyer,
International aviation accident lawyer,
Helicopter crash lawyer,
Sightseeing air tour accident,
Charter aircraft accident,
Medical aircraft crash,
Flight school accident,
Seaplane crash,
Air Balloon crash,

Fighting for the people…….Demanding truth, justice and accountability Airplane Crash Wrongful Death

GranuFlo Lawyers, NaturaLyte Lawsuits

Fresenius Medical is the manufacturer of GranuFlo and NaturaLyte acid concentrate. These are drugs used in dialysis treatment. There has been a recall of these dialysis drugs and lawsuits are being filed.

Injury and death has resulted from these drugs:

  • GranuFlo cardiovascular death,
  • GranuFlo sudden cardiac death,
  • GranuFlo cardiopulmonary arrest,
  • GranuFlo heart attack,
  • GranuFlo catastrophic cardiovascular injuries

Fresenius manufactures GranuFlo and NaturaLyte used in dialysis. These drugs cause alkalosis, a condition associated with an increase in cardiovascular fatalities.

The FDA received complaints describing alkali dosing errors that occurred during hemodialysis using dialysate concentrates containing acetic acid and acetate. When metabolized, these potential sources of alkali can contribute to elevated bicarbonate levels in patients undergoing hemodialysis.

This can contribute to metabolic alkalosis, which is a significant risk factor associated with :

Low blood pressure

Cardiopulmonary arrest

Cardiac arrhythmia

Sudden heart attack

Stroke

Hemodialysis cardiopulmonary arrest

A study which was conducted between January and December of 2010 found that patients with pre-dialysis bicarbonate levels greater than 28mEq/L were 4.7 times more likely to suffer a cardiac arrest. The study also discovered that patients with pre-dialysis potassium lower than 4 mEq/L had a 6.3 times higher risk of cardiac arrest.

In May 2012 the FDA notified health care providers to consider the presence and quantity of acetate, citrate, and/or acetic acid in dialysate concentrates when determining the patients’ dialysate prescription.

There is a GranuFlo and NaturaLyte Class 1 Recall

Serial numbers for recalled Naturalyte Liquid Acid Concentrate range from:

08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8, 08-3201-4, 08-3231-1, 08-3251-9, 08-3301-2, 08-4123-1, 08-4223-7, 08-4225-1, 08-4230- 2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1, 13-3251-9, 13-4123-1, 13-4220-1, 13-4225-1, 13-4325-

Serial numbers for recalled Naturalyte GranuFlo (powder) Acid Concentrate range from:

OFD1201-3B, OFD1251-3B, OFD2123-3B, OFD2201-38, OFD2220-3B, OFD2223-3B, OFD2225-3B, OFD2231-3 B, OFD2251-3B, OFD2301-3B, OFD2323-3 B, OFD2325-3B, OFD3201-3B, OFD3231-3B, OFD3251-3B, OFD3301-3B

GranuFlo & NaturaLyte is one of the most widely prescribed dry acid products used for dialysis at Fresenius clinics, as well as other hemodialysis centers that purchase their dialysis supplies from Fresenius. It is estimated that 125,000 patients in non-Fresenius clinics are treated with GranuFlo.

Dilaysis Patient Alert

If you, a loved one or someone you care for has been injured by these products contact us for a GranuFlo and NaturaLyte lawsuit.

Bladder Sling Lawyers, Vaginal Mesh Lawsuits

The bladder mesh is a vaginal mesh product primarily used for urinary incontinence. This mesh sling has caused severe complications and bladder mesh lawyers are filing lawsuits. Many women with a bladder mesh do not realize they are eligible to file a vaginal mesh lawsuit.

What is a Bladder Sling?

Urethral sling or bladder sling is used to treat urinary incontinence by placing a sling around the urethra to lift it back into a normal position and to exert pressure on the urethra to aid urine retention. The sling is attached to the abdominal wall. A bladder sling is a mesh device and is part of the vaginal mesh litigation. The complications of a failed bladder sling is increased incontinence or trouble voiding. Many women have needed to self catherize.

Bladder Sling Complications?

According to the July 2011 FDA news release, the most common complications associated with surgical mesh bladder slings is erosion thru the vaginal wall or into the bladder, pain during sexual intercourse, bleeding, infection, perforation of various pelvic organs (bladder, colon, vaginal walls), and urinary incontinence or problems voiding as well as; neuromuscular problems, emotional problems, mesh contraction/shrinkage, and even a reoccurrence of POP and/or SUI.

Bladder sling lawsuits are being filed on a contingency fee basis against the mnaufacturers of the bladder sling:

Bard Avaulta Support System
AMS Elevate Prolapse Repair System
AMS Apogee Vault Suspension System
AMS Perigee System
AMS Monarc Sling System
AMS Sparc Sling System
Ethicon Gynecare Gynemesh
Ethicon Gynecare Prolene Soft Mesh
Ethicon Gynecare Prolift Pelvic Floor Repair System
Ethicon Gynecare TVT Transvaginal Sling
Boston Scientific Pinnacle Pelvic Floor Repair Kit
Boston Scientific Uphold Vaginal Support System
UGYTEX Dual Knit Mesh
Coviden IVS Tunneler Sling

Contact us today.

Stryker Hip Replacement Lawyers, Stryker Hip Replacement Helpline

Adding to the Zimmer and DePuy metal on metal hip replacement Stryker has recalled it s latest metal component hip replacement implant. Stryker has voluntarily recalled the Rejuvenate metal component hip replacement implant and ABG II modular- neck stems
Stryker has voluntarily stopped market distribution of these hip replacements due to increased risk of injury. The hip replacement implants have been shown to fret or corrode, harming body tissue and causing pain and swelling. Other injuries include:

  • Severe inflammatory reactions
  • Pain in the groin
  • metal toxicity ort poisoning
  • high metal levels in the blood
  • need for additional surgery
  • Breakdown of muscles, tendons and other soft tissues in and around the hip joint
  • Loss of surrounding bone
  • Loss of mobility

While other types of hip implants such as those made by Johnson & Johnson and DePuy Orthopaedics Inc. involve a metal ball rubbing against a metal socket, the Stryker Rejuvenate products involve a metal neck inside a metal stem. The Stryker Hip replacement Helpline and hip replacement lawyers are reaching out to all victims of the failed device for a potential multi district litigation.

The products have metal components and although they are not metal on metal run the same risks of chromium and cobalt toxicity poisoning. If you have been injured you are advised to contact your doctor immediately and contact the Stryker Hip Replacement Helpline for a Stryker lawyer

Pradaxa Breaking News, Pradaxa lawyers, Pradaxa Lawsuits, Pradaxa Bleeding

Pradaxa has warnings for excessive bleeding. Pradaxa Helpline is concerned about Pradaxa and the elderly

The Pradaxa Helpline Has Pradaxa Lawyers to Help You

LONDON | Fri May 25, 2012 6:07am EDT

(Reuters) Doctors and patients should be given clearer guidance on how to avoid bleeding risks when using Boehringer Ingelheim s new stroke prevention pill Pradaxa, European regulators said on Friday.

The European Medicines Agency said data continued to confirm the positive benefit-risk balance of the anticoagulant medicine, despite cases of fatal bleeding, but advice on the risks should be strengthened.

Pradaxa is the first in a new class of medicines aimed at replacing the old and problematic drug warfarin. It is designed for use after hip and knee surgery and to prevent strokes in patients with atrial fibrillation, a form of irregular heartbeat common among the elderly.

Rival drugs include Xarelto, from Bayer and Johnson & Johnson, and Eliquis, from Bristol-Myers Squibb and Pfizer.

Pradaxa is an anticoagulant. Anticoagulants effect the clotting time of the blood. Pradaxa is described as a prescription blood-thinning medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. This can cause blood clots to form, increasing your risk of a stroke. Pradaxa lowers the chance of blood clots forming in your body. There is a chnce of excessive bleeding on Pradaxa that can be fatal.

We can locate a Pradaxa lawyer to help you:

Silicone Breast Implant Claims Lawyers, Silicone Breast Implant Class Action

Breast implant Class Action lawyers Helping women with Dow Corning, Mentor and other Silicone breast implant claims.

Silicone breast implants caused silicone toxicity and Immune deficiency diseases with symptoms of:

  • Muscle Pain -Upper arms, neck, chest, upper back, thighs, buttocks
  • Joint Pain -hands, feet, toes, elbows
  • Pressure headaches
  • Ringing in ears
  • Sun sensitivity & rash; face, neck & upper chest
  • Hives
  • Intermittent tingling in legs, feet, arms, fingers, right upper back, neck and face
  • Many urinary tract and yeast infections
  • Burning lips, mouth, tongue
  • Dry eyes, nose, mouth, and vagina
  • Nausea, heartburn, constipation, diarrhea
  • Insomnia
  • Anxiety

And:

  • Breast Pain
  • Upper and Lower Back Pain
  • dry eyes
  • joint pain and swelling
  • myalgias
  • chronic fatigue
  • Lupus
  • numbness and tingling in extremities
  • photosensitivity
  • Chemical Sensitivities
  • Muscle Pain, Stiffness, Unusual Fatigue
  • Excessive Hair Loss
  • Achy or Swollen Joints
  • Extreme fatigue
  • Skin Rashes
  • Rheumatoid Arthritis
  • Polymyositis-Dermatomyositis
  • Mixed Connective Tissue Disease
  • Scleroderma
  • Sjogren s syndrome
  • Anemia
  • Sensitivity to Sunlight
  • Kidney Problems
  • Fever
  • Difficulty Swallowing or Breathing

Women are still suffering today and settlements are still pending for the Silicone Breast Implant Clas Action. If you currently are registered fo r one of the breast implant settlement manufacturers and need help with your claim call 1 877 522-2123

Texas Lawyers For Victims of Pradaxa, Pradaxa Brain Hemorrhage

Texas pradaxa lawyers filing Pradaxa lawsuits for extensive bleeding and fatalities from pradaxa in Amarillo, Austin, Beaumont , Brownsville, College Station, Corpus Christi, Dallas, Denton, El Paso ,Fort Worth , Galveston, Houston, Huntsville, Killeen, Laredo, Lubbock, Mcallen, Odessa, San Antonio , San Marcos , Texarkana, Texoma, Tyler , Victoria , Waco , Wichita Falls , Logan

The recent death of a man due to a brain hemorrhage caused by a minor trauma has underscored the dangers of the blood thinner drug Pradaxa is very alarming as pradaxa is widely prescibed as a blood thinner for seniors

According to a report at MedPageToday.com on a case study conducted by researchers at University of Utah-Salt Lake City, an 83-year-old man’s condition worsened quickly soon after he was admitted to a hospital after suffering a minor fall. Intracranial Bleeding brain had spread quickly to half his brain, taking just six hours.

According to the Journal of Neurosurgery article, also reported on by Reuters (3/7/12), the subject of the case had been taking Pradaxa for one month when he suffered a seemingly harmless ground-level fall in his home. Upon first being admitted to the hospital, the patient was alert and responsive, showing no signs causing alarm. CT scans showed small, minor hemorrhaging in the man s brain.

Two hours after being admitted to the hospital, however, new CT scans showed that the brain hemorrhaging had progressed. Although doctors made efforts to stop the hemorrhaging, the patient fell into a coma and died.

Researchers concluded, "Imbalance and falls are common in this [elderly] population, and intracranial hemorrhage resulting from even minor trauma may occur with increasing frequency as use of this drug becomes more widespread," (3/6/12). They further noted that there is no way to reverse the effects of Pradaxa in emergency situations, putting patients who suffer relatively minor falls at risk of serious consequences.

Pradaxa has no antidote and can be harmful to a senior population prone to falls. What makes matters worse is that a brain beed has symptoms akin to dementia.

Pradaxa® Internal Bleeding

In November of 2011, a European counterpart to the FDA cited over 250 cases of fatal internal bleeding linked to Pradaxa® (a differently named version of Pradaxa® was on the market in Europe before it was released in the U.S.). The FDA has also received reports of Pradaxa®-associated internal bleeding here in the U.S.

Signs and symptoms of internal bleeding from Pradaxa include:

  • Throwing up blood or vomit that looks like coffee grounds,
  • Unexplained bleeding or bruising,
  • Swelling in the ankles, feet, lower legs, hands and/or arms,
  • Excess fatigue,
  • Nosebleeds, bleeding from the gums,
  • Coughing up blood,
  • Dark colored urine,
  • Gastrointestinal (GI) bleeding,
  • Internal bleeding,
  • Kidney bleeds,
  • Brain hemorrhaging,
  • Cerebral hemorrhage,

Less than a month after European regulators asked doctors to exercise caution about using the Pradaxa bloodthinner, the FDA has decided to investigate post-marketing reports of serious bleeding patients. As of November 6, the European Medicines Agency was aware of 256 cases of serious bleeding that results in patient deaths associated with the Boeheringer Ingelheim bloodthinner.

If you are a caregiver for someone on pradaxa watch them closely and talk to the physician about alternatives. If a loved one has symptoms of internal bleeding and is on pradaxa or you have lost someone due to Pradaxa contact a Pradaxa Lawyer

History of Breast Implants, Breast Implant Lawyers, Dow Corning breast Implant Claims

Breast Implant lawyers are still to this date helpling women resolve their Dow Corning Breast Implant Claims of the Breast Implant Class action of years ago. In light of this it is interesting to look at the history of Breast Implants, FDA has approved a New silicone breast Implant and despite the horrors women are still going for that well endowed look.

1940s
Japanese prostitutes have their breasts injected with substances such as paraffin, sponges and non-medical grade silicone to enlarge their breasts, believing that American servicemen favor women with large breasts.

1960s
The first silicone breast implants are developed by two plastic surgeons from Texas: Frank Gerow and Thomas Cronin.

1962
Timmie Jean Lindsey becomes the first woman to receive silicone breast implants.

1976
The Food and Drug Administration enacts the Medical Devices Amendment to the Federal Food, Drug and Cosmetic Act. FDA now has the authority to review and approve the safety and effectiveness data of new medical devices. But since silicone breast implants have been on the market for almost 15 years, they are "grandfathered." Manufacturers of the implants, when called to do so by the FDA, will be required to provide safety and effectiveness data.

1977
Richard Mithoff, a Houston attorney, wins the first lawsuit for a Cleveland woman who claims that her ruptured implants and subsequent operations had caused pain and suffering. She receives a $170,000 settlement from Dow Corning. Case receives little publicity.

1980s
Ralph Nader s Public Citizen Health Research Group, Washington, D.C. sends out warning signals that silicone breast implants cause cancer.

January 1982
FDA proposes to classify silicone breast implants into a Class III category which would require manufacturers to prove their safety in order to keep them on the market.

1984
Stern vs Dow Corning, San Francisco. Case wins on many internal Dow Corning documents that had been discovered in a Dow storage area by attorney Dan Bolton . Maria Stern s systemic autoimmune disease is found by a jury to be caused by her silicone breast implants. Bolton introduces the silicone-induced problems for the first time in court, with "experts" that theorize the silicone-immune system connection. After a monthlong trial, the jury awards Maria Stern $211,000 in compensatory damages and $1.5 million in punitive damages. The evidence is sealed by a court order.

June 1988
Six years after the 1982 proposal, FDA classifies the implants into Class III. Premarket Approval Applications from silicone breast implant manufacturers are due by July 1991. The PMA s must prove affirmatively, with valid scientific data evaluated by the FDA, that their devices are safe and effective. After the PMA s are submitted by the manufacturers, the FDA has 180 days to evaluate the safety data.

December 1990
Program on the dangers of silicone breast implants airs on "Face to Face with Connie Chung."

December 1990
Congressional hearing headed by Representative Ted Weiss deals with the safety of silicone breast implants. This hearing also discusses the fact that not all the information that the manufacturers have are available for public scrutiny due to a court order from the Stern verdict.

July 1991
Dow Corning releases 329 studies to FDA.

July 1991
Toole vs Baxter, Alabama. Jury decides against Baxter/Heyer-Shulte and awards the largest settlement so far, $5.4 million, to Brenda Toole. Toole, who shows only preliminary symptoms of systemic autoimmune problems, nevertheless had silicone in her lymphatic system according to plaintiffs witnesses and thus an increased risk of developing an autoimmune disease.

September 1991
FDA concludes that the silicone breast implant manufacturers safety data does not prove the devices are safe or harmful. Manufacturers are told to submit further data.

November 1991
The FDA brings together its General and Plastic Surgery Devices Panel to review all of the safety data from the manufacturers PMA s. The purpose of the panel is to advise FDA as to what they could tell the public about the safety and effectiveness of the silicone breast implants based on the PMA s. The panel is composed of a broad range of experts, including representatives from the fields of plastic surgery, oncology, epidemiology, internal medicine, immunology, radiology, pathology, gynecology, toxicology, sociology, biomaterials and psychology, as well as industry and consumer groups. The panel hearing rejects the data from Dow Corning, Mentor, McGhan, and Bioplasty, concluding there is not sufficient data about the risks and benefits of the devices. The panel recommends the devices stay on the market temporarily and with limited access. The need for more safety data is stressed.

December 1991
Hopkins vs Dow Corning, San Francisco. The largest award yet, $7.3 million, is given to Mariann Hopkins whose mixed connective- tissue disease is linked to her ruptured silicone breast implants. The lawyer for the case, Dan Bolton, wins the suit with the help of internal memos and studies from the Stern lawsuit, in addition to new studies he recently obtained from Dow. Mr. Bolton gives several of the internal documents to the FDA which has never seen the documents before.

December 1991
To date, 137 individual lawsuits have been filed against Dow Corning.

January 1992
FDA Commissioner, David Kessler, calls for a voluntary moratorium on the distribution or implantation of silicone breast implants until the FDA and the advisory panel have an opportunity to consider newly available information. The manufacturers agree.

February 1992
The class action lawsuit is filed in Cincinnati by Stan Chesley. The hope is to compensate women at a faster rate than filing individual lawsuits.

February 1992
Dow Corning CEO, Lawrence Reed, is replaced by Keith McKennon.

February 1992
The General and Plastic Surgery Devices Panel reconvenes to review the new information regarding the safety of silicone breast implants. The panel recommends that the further use of implants be limited for reconstruction only and that women receiving the implants participate in scientific protocols and that epidemiologic studies be conducted to assess the risk of autoimmune disease. The panel concludes that no causal link has been established between autoimmune disease and silicone breast implants.

February 1992
Many of the Dow Corning internal memos are released to the public.

March 1992
Dow Corning leaves the silicone breast implant business as do Bristol-Myers Squibb and Bioplasty. McGhan and Mentor will still manufacture breast implants. Dow sets up a fund for further research into the safety of breast implants.

April 1992
Dr. Kessler lifts the moratorium on silicone breast implants. The only women allowed to receive implant surgery are those undergoing breast reconstruction. All of the implant recipients must become part of a scientific protocol.

May 1992
First woman gets implants under new rules.

December 1992
Johnson vs Bristol-Myers Squibb, Houston. Pamela Jean Johnson wins $25 million, $5 million actual damages and $20 million punitive damages in a case argued by Texas attorney John O Quinn. A jury finds Ms. Johnson s ruptured silicone implants were linked to her mixed connective tissue disease, auto-immune responses, chronic fatigue, muscle pain, joint pain, headaches, and dizziness. Expert witnesses and lawyers admit her symptoms amount to "a bad flu."

December 1992
To date 3,558 individual lawsuits have been filed against Dow Corning.

June 1993
Dick Hazleton becomes CEO of Dow Corning.

December 1993
By year s end 12,359 individual lawsuits have been filed against Dow Corning.

March 1994
A Houston jury awards three women a total of $27.9 million against 3M, $15 million in punitive, $12 million in compensatory damages for illness. The lawyer arguing the case against 3M is John O Quinn. The three women suffered from either atypical lupus, neurological impairment, and a "silicone induced" autoimmune problem.

March 1994
The class action suit is finalized by manufacturers with Dow Corning being the largest contributor. The other contributors include Baxter, Bristol-Myers Squibb/MEC, 3M. It is the largest class action settlement in history. Manufacturers claim there is no scientific evidence linking silicone breast implants with autoimmune diseases. There are set monetary amounts that will be awarded to women with specific medical conditions. No requirements are needed to prove implants are the cause of their ailments. Women will be allowed to drop out of the settlement. Companies can also opt out if too few women register claims.

April 1994
Preliminary approval to class action by Judge Pointer. Clears the way for women to start applying for claims in the settlement.

June 1994
The Mayo Clinic epidemiologic study is published in the New England Journal of Medicine, which finds no increased risk of connective-tissue disease and other disorders that were studied in women with silicone implants.

September 1994
Final approval of class action/global settlement from Judge Pointer.

December 1994
By this date 19,092 individual lawsuits have been filed against Dow Corning.

1995
The American College of Rheumatology issues a statement saying the evidence is "compelling" that implants did not cause systemic disease.

February 1995
Gladys Laas vs Dow Corning.

May 1995
Dow Corning files for Chapter 11 bankruptcy. Dow is facing 20,000 lawsuits, some with multiple plaintiffs and about 410,000 potential claims that have been filed in the global settlement. The bankruptcy essentially halts all litigation.

June 1995
About 440,000 women have registered in the global settlement. About 70,000 can be immediately compensated.

June 1995
The Harvard Nurses Epidemiologic Study is published in the New England Journal of Medicine. This finds no increased risk of connective-tissue disease or certain signs and symptoms of connective-tissue disease in women with silicone implants.

October 1995
Mahlum vs Dow Chemical, Reno. This is the first case where Dow Chemical, the parent company of Dow Corning, is the sole defendant. Charlotte Mahlum is awarded $3.9 million in compensatory damages and $10 million in punitive damages. About 13,000 breast implant lawsuits are pending against Dow Chemical.

November 1995
New global settlement is devised minus Dow Corning. Bristol-Myers Squibb, Baxter and 3M are the participants. The monetary awards are less than the previous settlement.

December 1995
By now 15 individual lawsuits against Dow Corning have gone to trial involving some 19 plaintiffs. Of these, Dow Corning have had 8 trial "wins" and 6 trial "losses," with one split decision.

December 1995
By now more than 20 (non-case report) studies and abstracts have come out in the U.S. and internationally, all failing to support a causal relationship between silicone implants and a variety of auto-immune related illnesses.

April 1996
Two Federal judges in New York appoint an impartial, expert panel to review the scientific issues involved in breast implant lawsuits. This rare move will influence judges throughout the country.

September 1996
The California Court of Appeal upholds a decision dismissing Dow Chemical and Dow Corning from 1,800 breast-implant lawsuits.

December 1996
Oregon Federal Judge Robert E. Jones, after input from a panel of impartial scientists, rules that plaintiffs lawyers cannot present evidence that silicone implants caused disease because it is scientifically invalid. He dismisses 70 claims, shocking the litigation community.
Sam C. Pointer, the Alabama judge overseeing all federal implant cases, appoints his own panel of scientific experts who are not connected to implant litigation.

January 1997
The American Academy of Neurology reviews existing silicone implant studies and reports that "existing research shows no link between silicone breast implants and neurological disorders."

March 1997
A judge in Michigan rules that the Dow Chemical Company is not liable for the medical problems of hundreds of women in the state. Thus far, some state appellate courts have upheld Dow Chemical s liability and others have not.

August 1997
The New York Times reports that implant manufacturers have been winning 80% of cases against them. Nevertheless, a state jury in the first class-action suit finds that Dow Chemical (which owns half of Dow Corning) knowingly deceived women by hiding safety information about the silicone in their implants.

September 1997
The Journal of the National Cancer Institute publishes a review of scores of medical studies that concludes breast implants do not cause breast cancer. The researchers described the evidence for linking implants to any other disease as "borderline."

December 1997
The first class-action lawsuit in an implant case is reduced to its original eight claimants when a Louisiana judge decides the 1,800 women have cases too dissimilar to group into one lawsuit.

April 1998
Two large Scandinavian studies fail to show that silicone implants are linked to neurological disease.

July 1998
Plaintiffs agree to Dow Corning s offer of $3.2 billion to settle tens of thousands of claims of injury from silicone breast implants. The agreement will let the plaintiffs receive money within a year and also enable Dow Corning to emerge from bankruptcy proceedings.
After being asked by the British minister of health to review the safety of silicone implants, a seven-member panel of scientists report no convincing evidence that they cause disease. (The U.K. has never removed silicone implants from the market.)

November 1998
Dow Corning files for bankruptcy reorganization, which includes the $3.2 billion previously agreed-to settlement and offers claimants several payout options. Those who want to cash-out immediately and not file a disease claim will be paid $2,000. This figure can also be combined with $5,000 for implant removal surgery and $20,000 for a ruptured implant. Those who have already filed a disease claim will receive between $10,000 and $250,000 plus any compensation claimed for removal or ruptures.

December 1998
After two years and $800,000, a panel of four independent experts appointed by Judge Sam C. Pointer, overseer of implant lawsuits in the Federal courts, concludes that scientific evidence so far has failed to show that silicone breast implants cause disease.
Nevada Supreme Court upholds a compensatory damage award of $41 million against Dow Chemical to Charlotte Mahlum for her multiple-sclerosis-like symptoms. Dow Chemical was earlier found liable for helping Dow Corning conceal evidence about the harmful effects of silicone. The court, however, overturns a $10 million punitive award.

Breast Implant Class action, Breast Implant lawyers January 1999
A jury in a Washington Federal court awards $10 million in compensatory damages against Bristol-Myers Squibb Co. to an attorney who claimed her implants caused scleroderma.

Spring 1999 Silicone-gel-filled Breast implants
Silicone-gel-filled implants remain off the market in the U.S. pending manufacturer safety studies. They are available only to women who have had or will have breast surgery for a medical condition or have other complications from existing implants, and only if they agree to be part of a scientific protocol, or study. The latest status of silicone breast implants can be found at the FDA website.

June 1999
The Institute of Medicine releases a 400-page report prepared by an independent committee of 13 scientists. They conclude that although silicone breast implants may be responsible for localized problems such as hardening or scarring of breast tissue, implants do not cause any major diseases such as lupus or rheumatoid arthritis. The Institute of Medicine is part of the National Academy of Sciences, the nation s most prestigious scientific organization. Congress had asked the Institute to set up the committee. The committee did not conduct any original research; they examined past research and other materials, and conducted public hearings to hear all sides of the issue.

Pradaxa Heart Attack Complications, Pradaxa lawyer

Florida Pradaxa lawyers in Miami, Ft Lauderdale, Boca Raton, West Palm Beach, Orlando, Jacksonville, Hollywood, Ft Myers, Tampa, and all of Florida are accepting cases for heart Attacks form Pradaxa.

According to Boca raton Concierge doctors there are More Concerns about Pradaxa and .Myocardial Infarctions or Heart Attacks.
Posted on January 21, 2012 the medical comments are impressive and Florida lawyers are taking notice and accepting cases for injuries from Pradaxa. Pradaxa lawyers are accepting cases from victims of Pradaxa.

Pradaxa is part of a new group of anticoagulants (thrombin X inhibitors) that eventually will allow anticoagulation by the pill route without requiring patients to alter their food and medication intake and avoid foods and medications that interfere with the anticoagulant as patients must do with Warfarin. Pradaxa additionally eliminates the need to take blood tests (INR/ PT) to monitor the dosage as one has to do with Warfarin (Coumadin).

There is a large commercial advertising campaign underway on TV and print media to encourage patients with atrial fibrillation to ask their doctors to switch them from Coumadin to Pradaxa (Dabigatrin). Pradaxa lawyers are also advertising extensively regarding the dangers of pradaxa and offering a Pradaxa lawyer, The campaign bases its claims on the RE-LY trial of 18,000 patients at 80 medical centers throughout the world who took the 150 mg dosage and had significantly fewer strokes than patients taking Warfarin. The original study was criticized because many of the patients in the Warfarin (Coumadin) group were not on enough Warfarin or at a therapeutic PT/INR to prevent embolic strokes so the comparison with Pradaxa may not be valid. Another criticism involved the fact that Pradaxa can cause major bleeding and there is no antidote to stop the bleeding. Patients on Pradaxa who are bleeding are advised to undergo hemodialysis to remove the drug from their system because there are no medications or treatments available to stop Pradaxa related bleeding.

One wonders how the Food and Drug Administration approved this product for general use under these circumstances without conducting further testing? Pradaxa lawyers seem to believe these pradaxa complications and deaths are worthey of legal action and offering victims the opportunity to get a pradaxa lawyer and pursue a claim. The issue becomes even more confusing with the addition of data presented by Ken Uchino, MD, and Adrian Hernandez MD, PhD of the Cleveland Clinic in the online version of the Archives of Internal Medicine. They claim that by reviewing the RE-LY data there is a 38% relative increase in the risk of a myocardial infarction (MI) or heart attack in the Pradaxa group. In an accompanying editorial in the same journal, clinicians at the Hadassah- Hebrew University Medical Center in Jerusalem wrote, “The robust finding that Dabigatran is associated with increased rates of MI (heart attack) is alarming and emphasizes the need for continued critical appraisal of new drugs after phase III trials.”

Thrombin X inhibitors are the wave of the future. With no way to stop the bleeding, and data on their safety and efficacy still accumulating, they are just not ready for prime time yet. Pradaxa lawyers in Miami, Ft Lauderdale, Boca Raton, West Palm Beach, Orlando, Tampa, Clearwater, Sarasota, Ft Myers and all of Florida are helping victims of Pradaxa. Florida Pradaxa lawyers are helpling victim who have lost a loved one due to pradaxa.